Norbert G Riedel insider trades: Jazz Pharmaceuticals (JAZZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Norbert reports to the SEC
and 1 more company
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | JAZZ | ↓ Sell | 3,415 | $192.00 | $656K | Direct | Mar 2, 2026 (3d) |
| Aug 14, 2023 | JAZZ | ↓ Sell | 1,241 | $138.16 | $171K | Direct | Aug 15, 2023 (1d) |
| Aug 8, 2022 | JAZZ | ↓ Sell | 9,089 | $155.44 | $1.4M | Direct | Aug 9, 2022 (1d) |
| Dec 6, 2021 | APTX | ↑ Buy | 100,000 | $2.23 | $223K | By Riedel 2020 Irrevocable Trust | Dec 8, 2021 (2d) |
| Aug 6, 2021 | JAZZ | ↓ Sell | 1,306 | $147.96 | $193K | Direct | Aug 10, 2021 (4d) |
| Aug 7, 2020 | JAZZ | ↓ Sell | 931 | $125.87 | $117K | Direct | Aug 10, 2020 (3d) |
| Jan 10, 2020 | APTX | ↑ Buy | 35,000 | $3.00 | $105K | by Norbert G. Riedel 2015 Family Trust | Jan 14, 2020 (4d) |
| Aug 9, 2019 | JAZZ | ↓ Sell | 726 | $135.65 | $98K | Direct | Aug 12, 2019 (3d) |
| Nov 15, 2018 | ETON | ↑ Buy | 5,000 | $6.00 | $30K | Direct | Nov 15, 2018 (0d) |
| Aug 10, 2018 | JAZZ | ↓ Sell | 660 | $176.61 | $117K | Direct | Aug 13, 2018 (3d) |
| Jun 25, 2018 | APTX | ↑ Buy | 2,400 | $16.00 | $38K | By family members | Jun 26, 2018 (1d) |
| Aug 11, 2017 | JAZZ | ↓ Sell | 662 | $142.37 | $94K | Direct | Aug 14, 2017 (3d) |
| Aug 15, 2016 | JAZZ | ↓ Sell | 633 | $136.45 | $86K | Direct | Aug 17, 2016 (2d) |
| May 16, 2016 | JAZZ | ↓ Sell | 644 | $145.20 | $94K | Direct | May 17, 2016 (1d) |
| Aug 10, 2015 | JAZZ | ↓ Sell | 801 | $180.00 | $144K | Direct | Aug 11, 2015 (1d) |
| May 12, 2015 | JAZZ | ↓ Sell | 650 | $173.86 | $113K | Direct | May 14, 2015 (2d) |
| May 28, 2014 | JAZZ | ↓ Sell | 644 | $142.49 | $92K | Direct | May 29, 2014 (1d) |
| Aug 3, 2012 | BAX | ↓ Sell | 70,125 | $58.99 | $4.1M | Direct | Aug 6, 2012 (3d) |
| Mar 5, 2010 | BAX | ↓ Sell | 75,600 | $59.29 | $4.5M | Direct | Mar 9, 2010 (4d) |
| Dec 2, 2009 | BAX | ↓ Sell | 92,500 | $55.92 | $5.2M | Direct | Dec 4, 2009 (2d) |
| Jan 27, 2009 | BAX | ↓ Sell | 102,300 | $58.07 | $5.9M | Direct | Jan 28, 2009 (1d) |
| Jun 6, 2007 | BAX | ↓ Sell | 94,284 | $57.46 | $5.4M | Direct | Jun 7, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other JAZZ insiders
Open-market trades in the last 12 months
About Norbert G Riedel's insider trades
Norbert G Riedel is a director at Jazz Pharmaceuticals (JAZZ). Since Jun 6, 2007, Norbert has reported 4 open-market purchases worth $396K and 18 sales worth $28.5M on SEC Form 4. In the last 12 months: 1 sale ($656K).
Their filings also include grants and awards (56 filings), option exercises (14 filings), shares withheld for taxes (12 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JAZZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.